The U.S. minimally invasive spine device market is expected to reach $3 billion by 2019, according to a recent research from Reportlinker.com.
Spinal Tech
Raleigh, N.C.-based Baxano Surgical reached a $6 million settlement with the U.S. Department of Justice to settle its federal investigation related to an October 2011 subpoena.
Here are 10 recent news updates for spine and orthopedic device companies.
SpineGuard received COFEPRIS approval, which is Mexican regulatory clearance, to sell its Cannulated PediGuard device in the country.
Turkey-based Osimplant has launched the ARIA posterior lumbar interbody fusion cage insertion device.
Mazor Robotics received its first follow-up order for the Renaissance robotic spine system from a U.S. hospital corporation, an East Memphis-based full service hospital.
Lewisville, Texas-based Orthofix and its partner the Musculoskeletal Transplant Foundation have released the Trinity ELITE Allograft with Viable Cells and VersaShield Amniotic Membrane tissues.
New Jersey physician and researcher Hatem Sabaawy, MD, has conducted a clinical trial using adult stem cells to regenerate nerves in spinal cord injuries, according to a My Central Jersey report.
Nathan Littauer Hospital in Gloversville, N.Y., purchased a Renaissance spine system, the guided tool by Mazor Robotics that assists surgeons with the implantation of spine devices.
The Bethesda Orthopedic Institute in Boynton Beach, Fla., released its SUPERPATH hip replacement procedure designed to be less painful for patients.
